相关实验视频
Updated: Jun 12, 2025

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
阿克特激活的GSK3β抑制有效地阻断了的过酸化
Eunjin Lee1, Yujeong Lee1,2, Seonguk Yang1
1Department of Pharmacy, College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, 46241, Republic of Korea.
一种新型的抑制剂,GIP,在阿尔茨海默氏症 (AD) 模型中有效降低的过酸化. 这种有针对性的方法可以改善记忆缺陷,没有显著的副作用,为阿尔茨海默病提供了一种新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 高酸化和神经纤维状结与阿尔茨海默病 (AD) 的认知衰退相关.
- 糖原合成酶激酶3β (GSK3β) 的过度表达有助于陶过酸化,使其成为AD的治疗点.
- 现有的GSK3β抑制剂通常会引起副作用,因为它们会干扰基本的GSK3β功能.
研究的目的:
- 开发一种由Akt.激活的新型,向的GSK3β抑制 (GIP).
- 评估GIP在阻断GSK3β诱导的高酸化的疗效,在体外和体内.
- 评估GIP的神经保护作用和阿尔茨海默病的治疗潜力.
主要方法:
- 通过结合LRP6的PPPSPxS动机和GSK3β的Akt向序列,构建了一个新的GSK3β抑制 (GIP).
- 测试了GIP在海马同质体和神经母细胞细胞中抑制陶酸化的能力.
- 静脉注射GIP给3xTg-AD小鼠模型,以评估体内疗效和安全性.
主要成果:
- 在实验室中,GIP有效抑制了GSK3β诱导的陶酸化.
- 当GIP具有细胞透性时,它减少了神经母细胞瘤细胞中Aβ诱导的陶酸化和细胞死亡.
- 在体内,GIP显著降低了AD小鼠的海马陶酸化,改善了记忆力,并没有对Aβ斑块或神经炎症产生不良影响.
结论:
- 由Akt激活的GIP代表了一种针对阿尔茨海默病中高酸化的新疗法策略.
- GIP通过减少tau病理和改善认知缺陷来显示神经保护作用.
- 这种针对性抑制GSK3β为AD药物开发提供了有希望的方法,潜在的副作用较少.
更多相关视频
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
12:55Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
相关概念视频
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
TGF - β Signaling Pathway